Literature DB >> 20578807

Neutropenic enterocolitis in children and young adults with cancer: prognostic value of clinical and image findings.

Marcelo Rizzatti1, Silvia Regina Brandalise, Amilcar Cardoso de Azevedo, Vitória Régia Pereira Pinheiro, Simone dos Santos Aguiar.   

Abstract

Intensive chemotherapy regimens can result in severe toxicities, particularly those that involve the digestive systems, leading to morbidity and mortality in this group of patients. Acute enterocolitis can be a frequent complication. The authors performed a retrospective review or patients treated at their institution to ascertain the prognostic value of the clinical symptoms and signs of acute enterocolitis, the corresponding abdominal ultrasonographic findings, and the impact of previous chemotherapy. Amongst 1159 patients with cancer treated at the Centro Infantil Boldrini from 2003 to 2007, 188 (16.2%) patients had 1 or more episode of enterocolitis. An intestinal wall thickness of >or=3 mm on ultrasound was considered diagnostic of enterocolitis. There were 231 episodes of enterocolitis with a death rate of 11.7%. Previous therapy with cytarabine and the presence of abdominal distention affected survival. An intestinal wall thickness of >or=10 mm in the ultrasonographic examination was associated with greater mortality. In multivariate analysis, age, gender, tumor type, degree of neutropenia, intestinal wall thickness, and number of intestinal segments were not statistically significant difference. In children and young adults with cancer and enterocolitis, the clinical findings of 4 or more symptoms and presence of abdominal distention were associated with higher risk of death. Use of cytarabine and an intestinal wall thickness of >or=10 mm were associated with a higher death rate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578807     DOI: 10.3109/08880018.2010.489934

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  6 in total

Review 1.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Cryptosporidium gastroenteritis in Egyptian children with acute lymphoblastic leukemia: magnitude of the problem.

Authors:  S M A Hassanein; M M S Abd-El-Latif; O M Hassanin; L M S Abd-El-Latif; N I Ramadan
Journal:  Infection       Date:  2011-12-22       Impact factor: 3.553

3.  Neutropenic enterocolitis in pediatric leukemia patients treated with intensive chemotherapy in Upper Egypt.

Authors:  Ereen Refaat Fouad; Ahmed Mohammed Morsy; Hosam Eldein Mostafa Kamel; Amany Mohamed Ali
Journal:  Pediatr Investig       Date:  2020-03-17

4.  Embolisation for caecal bleeding in a child with typhlitis.

Authors:  Manou S de Lijster; Anne M Smets; Henk van den Berg; Jim A Reekers
Journal:  Pediatr Radiol       Date:  2014-06-12

5.  Bifidobacterium breve Sepsis in Child with High-Risk Acute Lymphoblastic Leukemia.

Authors:  Simona Lucija Avcin; Marko Pokorn; Lidija Kitanovski; Manica Mueller Premru; Janez Jazbec
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

Review 6.  Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).

Authors:  David Schnell; Elie Azoulay; Dominique Benoit; Benjamin Clouzeau; Pierre Demaret; Stéphane Ducassou; Pierre Frange; Matthieu Lafaurie; Matthieu Legrand; Anne-Pascale Meert; Djamel Mokart; Jérôme Naudin; Frédéric Pene; Antoine Rabbat; Emmanuel Raffoux; Patricia Ribaud; Jean-Christophe Richard; François Vincent; Jean-Ralph Zahar; Michael Darmon
Journal:  Ann Intensive Care       Date:  2016-09-15       Impact factor: 6.925

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.